Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Denamrk-based biopharmaceutical company Zealand Pharma has appointed David Solomon as the new CEO. Dr Solomon succeeds interim CEO Mogens Vang Rasmussen who will continue in his role as CFO.
Subscribe to our email newsletter
Most recently, Dr Solomon served as COO of Vital Sensors. Dr Solomon studied medicine and received his doctorate at Cornell University Medical College and the Sloan-Kettering division of its Graduate School of Medical Sciences, in New York City.
Daan Ellens, chairman of Zealand Pharma, said: “We are delighted to have David as the new CEO. He brings more than 20 years of experience in medical research, healthcare investing and key biopharmaceutical and medical device operating roles.
“His senior management experience, commercial and clinical development knowledge and investing background will be extremely valuable to the organization as the company moves forward.”